ENXTAM:PHARMBiotechs
Is Pharming Group (ENXTAM:PHARM) Pricing Lagging Its DCF And Sales-Based Valuation Estimates?
If you are wondering whether Pharming Group’s share price still reflects its true worth, you are not alone, especially after a strong run that has caught many investors’ attention.
The stock is currently at €1.35, with a 7 day return of 2.3% decline, a 30 day return of 7.1% decline, a year to date return of 7.7% decline, a 1 year return of 75.6% and a 3 year return of 17.4%, alongside a 5 year return of 18.9%.
Recent coverage around Pharming Group has focused on its position in the...